Source: PHARMACEUTICAL BUSINESS REVIEW

MLS: Meridian Life Science gets SBIR II by CDC to develop rotavirus vaccine

Meridian Life Science, of Memphis, Tennessee, a wholly-owned subsidiary of Meridian Bioscience, is proud to announce they have been selected by the Centers for Disease Control and Prevention (CDC) to develop a process for manufacture of a rotavirus vaccine.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jack Kenny's photo - CEO of Meridian Life Science, Inc.

CEO

Jack Kenny

CEO Approval Rating

- -/100

Read more